Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: A comparison with stereotactic vacuum assisted biopsy

Author:

Kasahara Mikiko1ORCID,Kanematsu Sayaka1,Tanaka Yoshihito1,Okazaki Satoshi1,Watatani Masahiro1

Affiliation:

1. Kansai Medical University Kori Hospital: Kansai Ika Daigaku Kori Byoin

Abstract

Abstract Background Tomosynthesis-guided vacuum assisted breast biopsy (3D-VAB) has been used increasingly and it is now replacing stereotactic vacuum assisted biopsy (2D-VAB). The aim of our study is to compare the clinical effectiveness of 3D-VAB and 2D-VAB on the number of tissue cores containing targeted calcifications and on the procedure time.Methods Consecutive 87 women who underwent biopsy at our hospital from April 2020 to March 2022 for calcifications mammographically suspicious of malignancy were included in this study: 57 patients with 3D-VAB and 30 patients with 2D-VAB. The procedure time was defined as the time between scout tomosynthesis for 3D-VAB and scout stereo images for 2D-VAB as a start and confirmation of targeted calcifications by specimen radiography as an end.Results Grouped or clustered calcified lesions were found in 39 and 21 patients among the 3D-VAB group and the 2D-VAB group, respectively. A mean long diameter and a mean area of the grouped or clustered calcified lesions of 39 patients were 9 mm and 50 mm2 from a MLO view. With the 21 cases of the 2D-VAB group, the corresponding figures were 10 mm and 78 mm2 from a MLO view. The mean number of tissue cores per biopsy containing targeted calcifications from the grouped or clustered calcified lesions was 3 and 2.3 specimens for 39 patients of the 3D-VAB group and for 21 patients of the 2D-VAB group, respectively. The mean procedure time for grouped or clustered calcifications was significantly shorter in the 3D-VAB group than in the 2D-VAB group (16.5 min vs. 27.4 min, P < 0.01). For all 87 patients, the mean procedure time was 18.1 minutes for 57 3D-VAB patients and 27.7 minutes for 30 2D-VAB patients, thus being significantly shorter with 3D-VAB than 2D-VAB (P < 0.01).Conclusion Our study demonstrated that the clinical performance of 3D-VAB is superior to that of 2D-VAB and that the significant reduction in examination time with 3D-VAB compared with 2D-VAB is expected to benefit patients.

Publisher

Research Square Platform LLC

Reference21 articles.

1. A history of breast cancer screening and future problems in Japan;Morimoto T;J Jpn Assoc Breast Cancer Screen,2009

2. Cancer Registry and Statistics. Cancer Information Service, Nationnal Cancer Center, Japan; https://ganjoho.jp/reg_stat/index.html.

3. Japan Radiological Society, Japanese Society of Radiological Technology. Mammography guideline. 4th ed. Tokyo: Igakushoin; 2021. (in Japanese).

4. Stereotactic breast biopsy with a biopsy gun;Parker SH;Radiology,1990

5. Stereotaxic core-needle biopsy for microcalcification;Tada T;Jpn J Breast Cancer,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3